Veronica Ravasio
Impact in
- Virology top 5%
- HIV Research and Treatment
- Infectious Diseases top 2%
- Antimicrobial Resistance in Staphylococcus
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- Antifungal resistance and susceptibility
Papers in
-
- Antimicrobial Resistance in Staphylococcus 12
- HIV/AIDS Research and Interventions 7
- HIV/AIDS drug development and treatment 7
- Epidemiology 17
- Infective Endocarditis Diagnosis and Management 13
- Co-authors
- Marco Rizzi (11 shared papers)Marco Falcone (7 shared papers)Fredy Suter (7 shared papers)Franco Maggiolo (7 shared papers)Maria Bruna Pasticci (8 shared papers)Paolo Grossi (5 shared papers)Fredy Suter (6 shared papers)Monica Airoldi (7 shared papers)
- Journals
- Infection (3 papers)Antiviral Therapy (2 papers)AIDS (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)HIV Clinical Trials (2 papers)
- Partner nations
- ItalyUnited StatesAustralia
In The Last Decade
Veronica Ravasio
25 papers receiving 770 citations
Peers
Comparison fields: 5 of 72
- Virology 162
- Infectious Diseases 581
- Epidemiology 492
- Clinical Biochemistry 84
- Emergency Medicine 85
Countries citing papers authored by Veronica Ravasio
This map shows the geographic impact of Veronica Ravasio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Veronica Ravasio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Veronica Ravasio more than expected).
Fields of papers citing papers by Veronica Ravasio
This network shows the impact of papers produced by Veronica Ravasio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Veronica Ravasio. The network helps show where Veronica Ravasio may publish in the future.
Co-authors
The 25 scholars most cited alongside Veronica Ravasio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 129 | |
| 2 | 2012 | 116 | |
| 3 | 2009 | 93 | |
| 4 | 2014 | 71 | |
| 5 | 2018 | 56 | |
| 6 | 2009 | 40 | |
| 7 | 2011 | 40 | |
| 8 | 2011 | 37 | |
| 9 | 2009 | 29 | |
| 10 | 2017 | 26 | |
| 11 | 2001 | 23 | |
| 12 | 2011 | 21 | |
| 13 | 2010 | 18 | |
| 14 | 2011 | 15 | |
| 15 | 2016 | 14 | |
| 16 | 2007 | 13 | |
| 17 | 2007 | 8 | |
| 18 | 2007 | 7 | |
| 19 | 2015 | 7 | |
| 20 | 2014 | 7 |
About Veronica Ravasio
Veronica Ravasio is a scholar working on Infectious Diseases, Epidemiology, Virology, Public Health, Environmental and Occupational Health and Clinical Biochemistry, having authored 25 papers that have together received 782 indexed citations. Recurring topics across this work include Infective Endocarditis Diagnosis and Management (13 papers), Antimicrobial Resistance in Staphylococcus (12 papers), HIV Research and Treatment (8 papers), HIV/AIDS Research and Interventions (7 papers), HIV/AIDS drug development and treatment (7 papers), Streptococcal Infections and Treatments (5 papers), Bacterial Identification and Susceptibility Testing (4 papers) and HIV-related health complications and treatments (2 papers). The work is most often cited by research in Virology (162 citations), Infectious Diseases (581 citations), Epidemiology (492 citations), Clinical Biochemistry (84 citations) and Emergency Medicine (85 citations). Veronica Ravasio has collaborated with scholars based in Italy, United States and Australia. Frequent co-authors include Marco Rizzi, Marco Falcone, Fredy Suter, Franco Maggiolo, Maria Bruna Pasticci, Paolo Grossi, Fredy Suter, Monica Airoldi, Claudio Arici and Annapaola Callegaro. Their work appears in journals such as Infection, Antiviral Therapy, AIDS, European Journal of Clinical Microbiology & Infectious Diseases and HIV Clinical Trials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.